BEAM
Price
$16.76
Change
-$0.39 (-2.27%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
1.69B
48 days until earnings call
VERV
Price
$11.21
Change
+$0.04 (+0.36%)
Updated
Jun 25, 04:59 PM (EDT)
Capitalization
997.62M
43 days until earnings call
Interact to see
Advertisement

BEAM vs VERV

Header iconBEAM vs VERV Comparison
Open Charts BEAM vs VERVBanner chart's image
Beam Therapeutics
Price$16.76
Change-$0.39 (-2.27%)
Volume$37.47K
Capitalization1.69B
Verve Therapeutics
Price$11.21
Change+$0.04 (+0.36%)
Volume$120.18K
Capitalization997.62M
BEAM vs VERV Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. VERV commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and VERV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (BEAM: $17.15 vs. VERV: $11.17)
Brand notoriety: BEAM and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 71% vs. VERV: 59%
Market capitalization -- BEAM: $1.69B vs. VERV: $997.62M
BEAM [@Biotechnology] is valued at $1.69B. VERV’s [@Biotechnology] market capitalization is $997.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, VERV is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while VERV’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 5 bearish.
  • VERV’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VERV is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +2.88% price change this week, while VERV (@Biotechnology) price change was -1.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +32.23%, and the average quarterly price growth was +16.56%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

VERV is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.69B) has a higher market cap than VERV($998M). VERV YTD gains are higher at: 98.050 vs. BEAM (-30.847). VERV has higher annual earnings (EBITDA): -201.62M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. VERV (497M). VERV has less debt than BEAM: VERV (68.6M) vs BEAM (158M). BEAM has higher revenues than VERV: BEAM (63.6M) vs VERV (59.6M).
BEAMVERVBEAM / VERV
Capitalization1.69B998M169%
EBITDA-399.03M-201.62M198%
Gain YTD-30.84798.050-31%
P/E RatioN/AN/A-
Revenue63.6M59.6M107%
Total Cash1.22B497M245%
Total Debt158M68.6M230%
TECHNICAL ANALYSIS
Technical Analysis
BEAMVERV
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTNX17.070.27
+1.61%
Artisan Select Equity Investor
MRSJX25.35N/A
N/A
MFS Research International R4
NGUAX30.01N/A
N/A
Neuberger Berman Large Cap Growth Inv
HSLVX45.20N/A
N/A
Hartford Small Cap Growth R6
DRRIX15.67N/A
N/A
BNY Mellon Global Real Return - I

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with ACXP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then ACXP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
+0.99%
ACXP - VERV
52%
Loosely correlated
+4.32%
CRSP - VERV
50%
Loosely correlated
+2.70%
BEAM - VERV
49%
Loosely correlated
+2.63%
IVEVF - VERV
46%
Loosely correlated
N/A
PRME - VERV
45%
Loosely correlated
+13.89%
More